Cardiac Toxicity of Targeted Therapies Used in the Treatment for Solid Tumours: A Review
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiac Toxicity of Targeted Therapies Used in the Treatment for Solid Tumours: A Review
Authors
Keywords
-
Journal
Cardiovascular Toxicology
Volume 12, Issue 3, Pages 191-207
Publisher
Springer Nature
Online
2012-04-21
DOI
10.1007/s12012-012-9164-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma.
- (2017) A. Ribas et al. JOURNAL OF CLINICAL ONCOLOGY
- AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer
- (2011) D. Grahame Hardie BIOCHEMICAL SOCIETY TRANSACTIONS
- Cancer Immunotherapy
- (2011) Robert O. Dillman CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Dasatinib: An Anti-Tumour Agent via Src Inhibition
- (2011) Antonio Gnoni et al. CURRENT DRUG TARGETS
- Sunitinib, Hypertension, and Heart Failure: A Model for Kinase Inhibitor-Mediated Cardiotoxicity
- (2011) Rajesh Gupta et al. CURRENT HYPERTENSION REPORTS
- Efficacy and Safety of Sirolimus and Everolimus in Heart Transplant Patients: A Retrospective Analysis
- (2011) B. Baur et al. TRANSPLANTATION PROCEEDINGS
- Cardiotoxicity
- (2010) I. Brana et al. ANNALS OF ONCOLOGY
- Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
- (2010) S. J. O'Day et al. ANNALS OF ONCOLOGY
- Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics
- (2010) Hui Cheng et al. CIRCULATION RESEARCH
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
- (2010) Markus M. Heiss et al. INTERNATIONAL JOURNAL OF CANCER
- Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress
- (2010) Vishnu Chintalgattu et al. JOURNAL OF CLINICAL INVESTIGATION
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Biomarkers in Chemotherapy-Induced Cardiotoxicity
- (2010) Daniela Cardinale et al. PROGRESS IN CARDIOVASCULAR DISEASES
- The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro
- (2010) Brian B. Hasinoff et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Cardiotoxicity induced by tyrosine kinase inhibitors
- (2009) George S. Orphanos et al. ACTA ONCOLOGICA
- Bevacizumab-associated hypertension: etiology, incidence, and management
- (2009) Sergio Huerta et al. ANTI-CANCER DRUGS
- Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy
- (2009) Emanuel Raschi et al. PHARMACOLOGY & THERAPEUTICS
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
- (2008) M. L. Telli et al. ANNALS OF ONCOLOGY
- Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab
- (2008) M. Scartozzi et al. ANNALS OF ONCOLOGY
- Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
- (2008) Ming Hui Chen et al. CIRCULATION
- Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems
- (2008) B. R.J. H. Bird et al. CLINICAL CANCER RESEARCH
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis
- (2008) Shenhong Wu et al. LANCET ONCOLOGY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Tackling heart failure in the twenty-first century
- (2008) James O. Mudd et al. NATURE
- Targeted Therapies for Metastatic Renal Cell Carcinoma: An Overview of Toxicity and Dosing Strategies
- (2008) T. E. Hutson et al. ONCOLOGIST
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search